Dr. Sanjay S. Shah

Dr. Rodriguez is Medical Director of the Wheelchair Seating Clinic and PM&R Administrator in the Michigan Bowel Control Clinic and the Wound Care Clinic. She has been actively involved in research with the Spinal Cord Injury Model System. She has written and collaborated on several research publications and written chapters on SCI sequelae in premier journals and textbooks in PM&R. Dr. Rodriguez has been recognized for her teaching of trainees with the Silver Crutch award. She is the associate SCI fellowship program director. She also serves on the International Standards and Autonomic Standards Committees, two crucial committees of the American Spinal Injury Association that are responsible for development of any new standards documents related to SCI, continuous review and improvement of the existing ASIA documents on neurological and autonomic standards and development and oversight of the International Data Sets project. Dr. Rodriguez is highly rated in 43 conditions, according to our data. Her clinical expertise encompasses Neurogenic Bowel, Paraplegia, Spasticity, and Autonomic Dysreflexia.

Stephen Goutman, MD, MS is an Associate Professor in the Department of Neurology and Director of the Amyotrophic Lateral Sclerosis Clinic and ALS Center of Excellence at Michigan Medicine. After obtaining a degree in neuroscience at the Johns Hopkins University (Baltimore, MD), Dr. Goutman completed his medical degree at the University of Chicago Pritzker School of Medicine (Chicago, IL) and his neurology residency and neuromuscular fellowship at Cleveland Clinic (Cleveland, OH). He received a Master’s in Clinical Research Design and Statistical Analysis at the University of Michigan (Ann Arbor, MI).Dr. Goutman evaluates and treats patients with neuromuscular diseases and is interested in diseases such as myasthenia gravis and muscle diseases. His area of expertise is amyotrophic lateral sclerosis (ALS)/Lou Gehrig’s Disease where his focus is delivering comprehensive and compassionate care. He is Director of the ALS Clinic, an ALS Association Certified Center of Excellence (http://www.umich-als.org/), where he leads a team of providers that care for persons with ALS and their families. Dr. Goutman is inspired by his patients and thus aims to provide the highest level of care.Dr. Goutman’s research is focused on identifying causes of and treatments for ALS. He leads research efforts that received funding by the National Institutes of Health and the Centers for Disease Control aimed at identifying environmental risk factors and causes of ALS (https://umhealthresearch.org/#studies/HUM00028826) and showed, in an article that received widespread attention, a connection between ALS and organochlorine pesticides (https://jamanetwork.com/journals/jamaneurology/fullarticle/2519875). Dr. Goutman also helps direct the University of Michigan ALS Biorepository which provides essential resources to ALS researchers within and external to the University of Michigan enabling studies into areas of ALS genetics, epigenetics, and immunology.Dr. Goutman is a site principal investigator of several multisite clinical trials focused on identifying new ALS treatments and causes and is an active participant with the Northeast ALS Consortium (NEALS) to improve care for ALS. He received a 2016 Young Investigator Award by the World Federation of Neurology Research Group on Motor Neuron Diseases. Dr. Goutman is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy. Dr. Goutman is board certified in Neurology, Neuromuscular Medicine, and Electrodiagnostic Medicine.

Daniel Menkes is a Neuromusculoskeletal Medicine specialist and a Neurologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 38 years. Dr. Menkes is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Myotonic Dystrophy, Myotonic Dystrophy Type 2, and Paramyotonia Congenita. Dr. Menkes is board certified in American Board Of Psychiatry And Neurology, American Board Of Psychiatry And Neurology, and American Board Of Psychiatry And Neurology. Dr. Menkes is currently accepting new patients.